Skip to main content
. 2015 Aug 19;10(8):e0133925. doi: 10.1371/journal.pone.0133925

Table 1. Patient Demographics and Disease Characteristics.

Patient Age (years) Sex Disease Duration (years) Baseline UCDAI Score Baseline Calprotectin (μg/g) Disease Extent Extraintestinal Manifestations Family Hx Smoker Prior Therapy Ongoing Therapy
1 47 F 26 6 1161 L-sided iritis/uveitis None s/p 13 yrs 5-ASA, Pred, herbal, VSL#3 5-ASA, Chinese herbs, curcumin
2 25 M 6 9 692 Pancolitis pystomatitis vegetans None No 5-ASA, AZA, infliximab None
3 61 F 40 8 366 Pancolitis none Brother and son with UC 1 cig/day 5-ASA, Pred, herbal, VSL#3 5-ASA, boswellia
5 29 M 7 6 280 L-sided none Mom with UC No 5-ASA, VSL#3 5-ASA
6 61 F 22 8 429 L-sided apthous stomatitis Mom with UC No 5-ASA, AZA None
7 27 F 8 8 209 L-sided possible sacroiliitis None 1 cig/week 5-ASA, Entocort, AZA 5-ASA
8 38 F 7 8 ND Pancolitis none None No 5-ASA, Pred, ABX, AZA, MTX, infliximab, adalimumab None

5-ASA = 5-aminosalicylic acid preparations, Pred = prednisone, AZA = azathioprine, ABX = antibiotics, MTX = methotrexate, UCDAI = ulcerative colitis disease activity index